Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wael A Shamseddeen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|June 6, 2007
Thalidomide and thrombosis. A meta-analysisRamzi N El Accaoui, Wael A Shamseddeen, Ali T Taher
Journal of Thrombosis and Thrombolysis|September 8, 2007
Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosisZaher K Otrock, Ali T Taher, Wael A Shamseddeen, et al.
Annals of Hematology|July 26, 2008
Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V LeidenZaher K Otrock, Ali T Taher, Wael A Shamseddeen, et al.
American Journal of Ophthalmology|October 3, 2006
Ocular findings among thalassemia patientsAli Taher, Ziad Bashshur, Wael A Shamseddeen, et al.
Annals of Hematology|July 11, 2006
Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trialZaher K Otrock, Sami T Azar, Wael A Shamseddeen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|June 6, 2007
Thalidomide and thrombosis. A meta-analysisRamzi N El Accaoui, Wael A Shamseddeen, Ali T Taher
Journal of Thrombosis and Thrombolysis|September 8, 2007
Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosisZaher K Otrock, Ali T Taher, Wael A Shamseddeen, et al.
Annals of Hematology|July 26, 2008
Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V LeidenZaher K Otrock, Ali T Taher, Wael A Shamseddeen, et al.
American Journal of Ophthalmology|October 3, 2006
Ocular findings among thalassemia patientsAli Taher, Ziad Bashshur, Wael A Shamseddeen, et al.
Annals of Hematology|July 11, 2006
Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trialZaher K Otrock, Sami T Azar, Wael A Shamseddeen, et al.
Pageof 1